Physiology Section, Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona (UB), 08028 Barcelona, Spain.
Nutrition and Food Safety Research Institute (INSA-UB), 08921 Santa Coloma de Gramenet, Spain.
Nutrients. 2022 Mar 10;14(6):1163. doi: 10.3390/nu14061163.
Rotavirus (RV) is the main cause of gastroenteritis in children. Prebiotics and, more recently, postbiotics are used for preventing and treating gastrointestinal infections. The aim of this study was to analyze the effects of a Lactofidus, short-chain galacto-oligosaccharides (scGOS) and long-chain fructo-oligosaccharides (lcFOS) mixture, and their combination on RV infection, in a rat model, for early life diarrhea. Fifteen litters of suckling rats were intragastrically administered daily with the vehicle, the prebiotic mixture, the postbiotic or the combination. The RV was inoculated on day 5 and then fecal samples were clinically evaluated daily. Viral shedding, intestinal permeability assay, in vitro blocking assay, immunoglobulin profiles, and anti-RV response were assessed at day 8 and 16 of life. Cecal microbiota composition, intestinal gene expression, and short chain fatty acids (SCFAs) were analyzed at day 16. The incidence and severity of diarrhea were significantly reduced by all the supplementations. Moreover, they showed blocking activity, changes in the immunoglobulin profiles, in gut microbiota, and in the intestinal gene expression. The prebiotic mixture reduced gut permeability and changed the SCFA profile, whereas the postbiotic enhanced the expression of Toll-like receptors (TLRs). The combination preserved most of the individual observed effects, and furthermore, complementary effects, such as an increase in white blood cells and lymphocytes recruitment, as well as upregulation of TLR7 and TLR9 gene expression.
轮状病毒(RV)是导致儿童肠胃炎的主要原因。益生元和后生元最近被用于预防和治疗胃肠道感染。本研究旨在分析一种含有短链半乳糖寡糖(scGOS)和长链果糖寡糖(lcFOS)混合物及其组合的 Lactofidus 对生命早期腹泻的 RV 感染的影响。15 窝哺乳期大鼠每天经胃内给予载体、益生元混合物、后生元和组合。RV 于第 5 天接种,然后每天对粪便样本进行临床评估。在第 8 天和第 16 天评估病毒脱落、肠道通透性测定、体外阻断试验、免疫球蛋白谱和抗 RV 反应。在第 16 天分析盲肠微生物群组成、肠道基因表达和短链脂肪酸(SCFA)。所有补充剂均能显著降低腹泻的发生率和严重程度。此外,它们还表现出阻断活性、免疫球蛋白谱变化、肠道微生物群和肠道基因表达的变化。益生元混合物降低了肠道通透性并改变了 SCFA 谱,而后生元增强了 Toll 样受体(TLR)的表达。组合保留了大多数单独观察到的效果,并且还具有互补作用,例如增加白细胞和淋巴细胞募集,以及 TLR7 和 TLR9 基因表达的上调。